Several other reports have confirmed the high frequency of PIK3CA mutations and of other members of the PI3K pathway in DCIS, but it is unclear whether these genetic alterations play a role in the progression of DCIS to IDC [297,298,299]. This evidence concerns the gene PIK3CA and ductal breast carcinoma in situ.